Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
    • R&D
    • PENAO
      • PENAO Introduction
      • About
      • Board & Senior Management
      • Asset Protection
      • Research & Development​
      • Value Proposition
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni GuangDong
    • By Beroni Tianjin
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
Menu Close

Monthly Archives: April 2018

  1. Home>
  2. 2018>
  3. April
Read more about the article Labor Union Activity of Beroni —— A Trip To Beijing WTown
Having delicious dinner

Labor Union Activity of Beroni —— A Trip To Beijing WTown

  • Post author:admin
  • Post published:2018-04-26
  • Post category:2018

On April 21, some members of Labor Union of Beroni started the trip to Beijing WTown. Beijing WTown located in northeast of Miyun County is an ancient town that was rebuilt…

Continue ReadingLabor Union Activity of Beroni —— A Trip To Beijing WTown
Read more about the article Beroni Group Investment into Dendrix. Inc
Signing of the agreement between Beroni Group and Dendrix

Beroni Group Investment into Dendrix. Inc

  • Post author:admin
  • Post published:2018-04-10
  • Post category:2018

Tokyo - 9 April 2018, Mr Zhang Boqing, Chairman of Beroni Group and Mr Shigeru Hirabayashi, Chairman of Dendrix. Inc signed an agreement for investment and acquisition.   Nowadays, human health issues…

Continue ReadingBeroni Group Investment into Dendrix. Inc

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)
  • 2023 (6)
  • 2024 (8)
  • 2025 (1)

What’s New

  • Beroni Pharmaceuticals Nucleic Acid Drug CRO Services
  • Beroni Group’s AI-based Drug R&D Model Achieves Technological Breakthrough
  • Beroni Group Has Made Significant Progress in the Field of iNKT Cell Anti-tumor Therapy
  • Beroni Group Has Successfully Developed a New Method for Improving Safety of Neural Stem Cells Used in the Treatment of Neurodegenerative Diseases
  • Beroni Group’s Ten-year Research Journey, Innovation Leads the Future

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu